These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 21798463

  • 1. Fact and fiction in tuberculosis vaccine research: 10 years later.
    Kaufmann SH.
    Lancet Infect Dis; 2011 Aug; 11(8):633-40. PubMed ID: 21798463
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. Novel tuberculosis vaccines on the horizon.
    Parida SK, Kaufmann SH.
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [Abstract] [Full Text] [Related]

  • 4. Advances in tuberculosis vaccine strategies.
    Skeiky YA, Sadoff JC.
    Nat Rev Microbiol; 2006 Jun; 4(6):469-76. PubMed ID: 16710326
    [Abstract] [Full Text] [Related]

  • 5. A new TB vaccine: fact or fiction?
    van Helden PD, Hoal EG.
    Comp Immunol Microbiol Infect Dis; 2013 May; 36(3):287-94. PubMed ID: 22921282
    [Abstract] [Full Text] [Related]

  • 6. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S, Heidary M, Haeili M, Drancourt M, Darban-Sarokhalil D, Nasiri MJ, Lohrasbi V.
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [Abstract] [Full Text] [Related]

  • 7. Tuberculosis vaccine research: the impact of immunology.
    Barker LF, Brennan MJ, Rosenstein PK, Sadoff JC.
    Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C.
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT, Soonawala D, Joosten SA, Prins C, Arend SM, Bang P, Tingskov PN, Lingnau K, Nouta J, Hoff ST, Rosenkrands I, Kromann I, Ottenhoff TH, Doherty TM, Andersen P.
    Vaccine; 2011 Mar 03; 29(11):2100-9. PubMed ID: 21256189
    [Abstract] [Full Text] [Related]

  • 12. Progress in tuberculosis vaccine development.
    Baumann S, Nasser Eddine A, Kaufmann SH.
    Curr Opin Immunol; 2006 Aug 03; 18(4):438-48. PubMed ID: 16777396
    [Abstract] [Full Text] [Related]

  • 13. Clinical Testing of Tuberculosis Vaccine Candidates.
    Hatherill M, Tait D, McShane H.
    Microbiol Spectr; 2016 Oct 03; 4(5):. PubMed ID: 28087924
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recent findings in immunology give tuberculosis vaccines a new boost.
    Kaufmann SH.
    Trends Immunol; 2005 Dec 03; 26(12):660-7. PubMed ID: 16246622
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of novel carrier(s) mediated tuberculosis vaccine: more than a tour de force.
    Garg NK, Dwivedi P, Jain A, Tyagi S, Sahu T, Tyagi RK.
    Eur J Pharm Sci; 2014 Oct 01; 62():227-42. PubMed ID: 24909731
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.